WallStSmart

DaVita HealthCare Partners Inc (DVA)vsPACS Group, Inc. (PACS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

DaVita HealthCare Partners Inc generates 158% more annual revenue ($13.64B vs $5.29B). DVA leads profitability with a 5.5% profit margin vs 3.6%. DVA appears more attractively valued with a PEG of 0.56. DVA earns a higher WallStSmart Score of 66/100 (B-).

DVA

Strong Buy

66

out of 100

Grade: B-

Growth: 6.0Profit: 7.0Value: 8.7Quality: 4.3
Piotroski: 3/9Altman Z: 1.22

PACS

Buy

58

out of 100

Grade: C

Growth: 8.7Profit: 6.0Value: 10.0Quality: 3.5
Piotroski: 5/9Altman Z: 1.32
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DVAUndervalued (+11.7%)

Margin of Safety

+11.7%

Fair Value

$163.40

Current Price

$155.11

$8.29 discount

UndervaluedFair: $163.40Overvalued
PACSUndervalued (+31.4%)

Margin of Safety

+31.4%

Fair Value

$57.10

Current Price

$32.61

$24.49 discount

UndervaluedFair: $57.10Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DVA3 strengths · Avg: 8.7/10
Return on EquityProfitability
64.8%10/10

Every $100 of equity generates 65 in profit

PEG RatioValuation
0.568/10

Growing faster than its price suggests

P/E RatioValuation
16.1x8/10

Attractively priced relative to earnings

PACS2 strengths · Avg: 9.5/10
EPS GrowthGrowth
57.2%10/10

Earnings expanding 57.2% YoY

Return on EquityProfitability
23.0%9/10

Every $100 of equity generates 23 in profit

Areas to Watch

DVA3 concerns · Avg: 2.7/10
Profit MarginProfitability
5.5%3/10

5.5% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

PACS4 concerns · Avg: 2.8/10
P/E RatioValuation
27.6x4/10

Moderate valuation

Profit MarginProfitability
3.6%3/10

3.6% margin — thin

Free Cash FlowQuality
$-15.97M2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
1.322/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : DVA

The strongest argument for DVA centers on Return on Equity, PEG Ratio, P/E Ratio. PEG of 0.56 suggests the stock is reasonably priced for its growth.

Bull Case : PACS

The strongest argument for PACS centers on EPS Growth, Return on Equity. Revenue growth of 12.4% demonstrates continued momentum. PEG of 1.03 suggests the stock is reasonably priced for its growth.

Bear Case : DVA

The primary concerns for DVA are Profit Margin, Piotroski F-Score, Altman Z-Score.

Bear Case : PACS

The primary concerns for PACS are P/E Ratio, Profit Margin, Free Cash Flow. Debt-to-equity of 4.93 is elevated, increasing financial risk. Thin 3.6% margins leave little buffer for downturns.

Key Dynamics to Monitor

PACS is growing revenue faster at 12.4% — sustainability is the question.

DVA generates stronger free cash flow (395M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

DVA scores higher overall (66/100 vs 58/100). PACS offers better value entry with a 31.4% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

DaVita HealthCare Partners Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.

PACS Group, Inc.

HEALTHCARE · MEDICAL CARE FACILITIES · USA

PACS Group, Inc. is a leading technology solutions provider focused on enhancing operational efficiency and productivity across a wide array of industries. The company excels in developing innovative software and hardware systems that optimize workflows and enhance data management capabilities. With a strong commitment to research and development, PACS Group is well-positioned to capitalize on emerging technological trends, reinforcing its status as a key player in the digital transformation landscape. Its strategic partnerships and extensive market presence further strengthen its competitive advantage, presenting a compelling investment opportunity for institutional investors seeking growth in the evolving technology sector.

Visit Website →

Want to dig deeper into these stocks?